Akoya Biosciences (AKYA)
NASDAQ:AKYA
US Market

Akoya Biosciences (AKYA) Stock Investors

127 Followers
Based on 748,394 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold AKYA
On average, investors allocate 0.00% of their portfolios to AKYA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 748,394 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding AKYA

1.7%
Last 7
Days
5.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding AKYA, out of 748,394 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

AKYA Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,213 investors who made their portfolios public
The table shows changes in AKYA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

AKYA Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.77%
-1.15%
-1.80%
31.40B
Consumer Cyclical
ChargePoint Holdings
4.18%
-1.34%
-2.69%
863.37M
Consumer Cyclical
Airbnb
4.49%
-1.44%
+1.50%
90.19B
Consumer Cyclical
UiPath
3.33%
-1.20%
-2.42%
6.99B
Technology
Marathon Digital Holdings
5.54%
-1.09%
+0.30%
5.54B
Financial
Applied Materials
4.55%
+0.13%
+5.46%
167.52B
Technology
Block
4.15%
-0.94%
-0.27%
38.00B
Technology
Merck & Company
3.91%
-0.38%
+3.17%
318.75B
Healthcare
Fortinet
3.35%
-0.52%
-0.99%
43.78B
Technology
Riot Platforms
5.10%
-0.52%
+0.86%
3.10B
Financial
Based on the activity of 748,394 active portfolios
Open your Smart Portfolio

AKYA Investor Analysis

AKYA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.3%
of AKYA holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
AKYA investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
37.5%
of AKYA holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
AKYA investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
56.3%
of AKYA holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of AKYA stock investors
See who invests in AKYA according to age group and performance.

FAQ

How many retail Investors hold AKYA?
<0.1% of TipRanks' retail investors hold AKYA in their portfolios.
    What is AKYA Investor Sentiment?
    AKYA’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of AKYA in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of AKYA in the last 7 days.
        What percentage of retail investors changed their holding of AKYA in the last 30 days?
        ▼ 5.8% of TipRanks' retail investors changed their holding of AKYA in the last 30 days.
          What is the average age of retail investors who hold AKYA?
          The average age of AKYA Holders is over 55.
            What other stocks have AKYA investors also bought?
            AKYA Investors also bought DKNG, CHPT, ABNB, PATH, MARA, AMAT, SQ, MRK, FTNT, RIOT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BAXBaxter International
              CRLCharles River Labs
              AVDLAvadel Pharmaceuticals
              HAEHaemonetics
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis